Compile Data Set for Download or QSAR
maximum 50k data
Found 1883 Enz. Inhib. hit(s) with Target = 'Somatostatin receptor type 5'
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144757(US8952128, 15)
Affinity DataKi:  0.0800nM ΔG°:  -57.6kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144752(US8952128, 11)
Affinity DataKi:  0.0900nM ΔG°:  -57.3kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144751(US8952128, 10)
Affinity DataKi:  0.160nM ΔG°:  -55.9kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144755(US8952128, 13)
Affinity DataKi:  0.230nM ΔG°:  -55.0kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144761(US8952128, 20)
Affinity DataKi:  0.330nM ΔG°:  -54.1kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144756(US8952128, 14)
Affinity DataKi:  0.360nM ΔG°:  -53.9kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144748(US8952128, 7)
Affinity DataKi:  0.510nM ΔG°:  -53.0kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144742(US8952128, 6)
Affinity DataKi:  0.520nM ΔG°:  -53.0kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144768(US8952128, 27)
Affinity DataKi:  0.530nM ΔG°:  -52.9kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144753(US8952128, 12 | US8952128, 46)
Affinity DataKi:  0.740nM ΔG°:  -52.1kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144776(US8952128, 33)
Affinity DataKi:  0.820nM ΔG°:  -51.9kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144759(US8952128, 17)
Affinity DataKi:  0.860nM ΔG°:  -51.7kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144740(US8952128, 4)
Affinity DataKi:  0.920nM ΔG°:  -51.6kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144766(US8952128, 25)
Affinity DataKi:  0.950nM ΔG°:  -51.5kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144786(US8952128, 44)
Affinity DataKi:  1.38nM ΔG°:  -50.6kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144749(US8952128, 8)
Affinity DataKi:  1.49nM ΔG°:  -50.4kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144750(US8952128, 9)
Affinity DataKi:  1.54nM ΔG°:  -50.3kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144773(US8952128, 30 | US8952128, 32)
Affinity DataKi:  1.58nM ΔG°:  -50.2kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144741(US8952128, 5)
Affinity DataKi:  1.65nM ΔG°:  -50.1kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144771(US8952128, 29)
Affinity DataKi:  2.37nM ΔG°:  -49.2kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144765(US8952128, 24)
Affinity DataKi:  2.39nM ΔG°:  -49.2kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144779(US8952128, 37)
Affinity DataKi:  2.45nM ΔG°:  -49.1kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123280(US8742110, 5-16)
Affinity DataIC50:  1.81nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123281(US8742110, 5-17)
Affinity DataIC50:  210nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123282(US8742110, 5-18)
Affinity DataIC50:  45.3nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123283(US8742110, 6-1)
Affinity DataIC50:  1.17E+3nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123284(US8742110, 6-2)
Affinity DataIC50:  1.74E+3nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123285(US8742110, 6-3)
Affinity DataIC50:  156nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123286(US8742110, 6-4)
Affinity DataIC50:  98.7nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123287(US8742110, 6-5)
Affinity DataIC50:  149nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123288(US8742110, 6-6)
Affinity DataIC50:  68.1nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123289(US8742110, 6-7)
Affinity DataIC50:  1.20E+3nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123290(US8742110, 6-8)
Affinity DataIC50:  1.20E+3nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123291(US8742110, 6-9)
Affinity DataIC50:  121nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123292(US8742110, 6-10)
Affinity DataIC50:  137nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123293(US8742110, 6-11)
Affinity DataIC50:  410nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123294(US8742110, 6-12)
Affinity DataIC50:  216nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123295(US8742110, 6-13)
Affinity DataIC50:  185nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123296(US8742110, 6-14)
Affinity DataIC50:  0.260nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123297(US8742110, 6-15)
Affinity DataIC50:  1.20E+3nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123298(US8742110, 6-16)
Affinity DataIC50:  0.851nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123299(US8742110, 6-17)
Affinity DataIC50:  61.6nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123300(US8742110, 6-18)
Affinity DataIC50:  0.225nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123301(US8742110, 6-19)
Affinity DataIC50:  6.79nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123302(US8742110, 6-20)
Affinity DataIC50:  1.06nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123303(US8742110, 6-21)
Affinity DataIC50:  11.7nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123304(US8742110, 6-22)
Affinity DataIC50:  8.64nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123305(US8742110, 6-23)
Affinity DataIC50:  9.06nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123306(US8742110, 6-24)
Affinity DataIC50:  0.342nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123307(US8742110, 6-25)
Affinity DataIC50:  0.550nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 1883 total ) | Next | Last >>
Jump to: